{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:57:21Z","timestamp":1761562641205,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006083","name":"AGA Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006083","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.cgh.2020.05.022","type":"journal-article","created":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T02:03:32Z","timestamp":1589681012000},"page":"43-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Health Economic Studies Are Important for Patients With Irritable Bowel Syndrome and Their Gastroenterologists"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3611-8628","authenticated-orcid":false,"given":"Eric D.","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah K.","family":"Ballou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2020.05.022_bib1","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/ajg.2016.574","article-title":"Comparison of symptoms, healthcare utilization, and treatment in diagnosed and undiagnosed individuals with diarrhea-predominant irritable bowel syndrome","volume":"112","author":"Sayuk","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.05.022_bib2","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.cgh.2019.08.016","article-title":"Effects of irritable bowel syndrome on daily activities vary among subtypes based on results from the IBS in America Survey","volume":"17","author":"Ballou","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.05.022_bib3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cgh.2020.04.003","article-title":"Patients with irritable bowel syndrome are willing to take substantial medication risks\u00a0for symptom relief","volume":"19","author":"Shah","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.05.022_bib4","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cgh.2020.02.030","article-title":"Systems-based strategies to consider treatment costs in clinical practice","volume":"18","author":"Shah","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.05.022_bib5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/0003-4819-118-8-199304150-00009","article-title":"Measuring health-related quality of life","volume":"118","author":"Guyatt","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2020.05.022_bib6","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.cgh.2019.02.039","article-title":"Value-based pricing for rifaximin increases access of patients with irritable bowel syndrome with diarrhea to therapy","volume":"17","author":"Shah","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.05.022_bib7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2020.05.022_bib8","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1038\/ajg.2009.232","article-title":"Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort","volume":"104","author":"Spiegel","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.05.022_bib10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.14309\/ajg.0000000000000530","article-title":"Evaluating when and why patients discontinue chronic therapy for irritable bowel syndrome with constipation and chronic idiopathic constipation","volume":"115","author":"Shah","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.05.022_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/apt.15325","article-title":"Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome","volume":"50","author":"Zamani","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2020.05.022_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.12982","article-title":"The impact of irritable bowel syndrome on daily functioning: characterizing and understanding daily consequences of IBS","volume":"29","author":"Ballou","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2020.05.022_bib13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/ajg.2011.485","article-title":"IBS patients\u2019 willingness to take risks with medications","volume":"107","author":"Lacy","year":"2012","journal-title":"Am J Gastroenterol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356520306819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356520306819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:32:32Z","timestamp":1761543152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356520306819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1542356520306819"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2020.05.022","relation":{},"ISSN":["1542-3565"],"issn-type":[{"type":"print","value":"1542-3565"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health Economic Studies Are Important for Patients With Irritable Bowel Syndrome and Their Gastroenterologists","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2020.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2020.04.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the AGA Institute","name":"copyright","label":"Copyright"}]}}